Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexey Goltsov

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Biomolecules|September 23, 2022
Three Grand Challenges in High Throughput Omics TechnologiesPrashanth Suravajhala, Alexey Goltsov
Electromagnetic Biology and Medicine|October 7, 2020
Collective excitations in α-helical protein structures interacting with the water environmentVasiliy N Kadantsev, Alexey Goltsov
Pharmaceuticals (Basel, Switzerland)|September 26, 2020
Cycle Network Model of Prostaglandin H Synthase-1Alexey Goltsov, Maciej Swat, Kirill Peskov, et al.
Frontiers in Oncology|February 20, 2014
Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinationsAlexey Goltsov, Simon P Langdon, Gregory Goltsov, et al.
Diagnostics (Basel, Switzerland)|November 11, 2022
Diagnostics of Ovarian Tumors in Postmenopausal PatientsChingis Mustafin, Sergey Vesnin, Arran Turnbull, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1Alexey Goltsov, Galina Lebedeva, Ian Humphery-Smith, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 12, 2016
Kinetic modelling of in vitro data of PI3K, mTOR1, PTEN enzymes and on-target inhibitors Rapamycin, BEZ235, and LY294002Alexey Goltsov, Ghassan Tashkandi, Simon P Langdon, et al.
Cellular Signalling|October 15, 2011
Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibitionAlexey Goltsov, Dana Faratian, Simon P Langdon, et al.
Cellular Signalling|October 19, 2010
Compensatory effects in the PI3K/PTEN/AKT signaling network following receptor tyrosine kinase inhibitionAlexey Goltsov, Dana Faratian, Simon P Langdon, et al.
Journal of Biotechnology|December 3, 2014
Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cellsHilal S Khalil, Alexey Goltsov, Simon P Langdon, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Biomolecules|September 23, 2022
Three Grand Challenges in High Throughput Omics TechnologiesPrashanth Suravajhala, Alexey Goltsov
Electromagnetic Biology and Medicine|October 7, 2020
Collective excitations in α-helical protein structures interacting with the water environmentVasiliy N Kadantsev, Alexey Goltsov
Pharmaceuticals (Basel, Switzerland)|September 26, 2020
Cycle Network Model of Prostaglandin H Synthase-1Alexey Goltsov, Maciej Swat, Kirill Peskov, et al.
Frontiers in Oncology|February 20, 2014
Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinationsAlexey Goltsov, Simon P Langdon, Gregory Goltsov, et al.
Diagnostics (Basel, Switzerland)|November 11, 2022
Diagnostics of Ovarian Tumors in Postmenopausal PatientsChingis Mustafin, Sergey Vesnin, Arran Turnbull, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1Alexey Goltsov, Galina Lebedeva, Ian Humphery-Smith, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 12, 2016
Kinetic modelling of in vitro data of PI3K, mTOR1, PTEN enzymes and on-target inhibitors Rapamycin, BEZ235, and LY294002Alexey Goltsov, Ghassan Tashkandi, Simon P Langdon, et al.
Cellular Signalling|October 15, 2011
Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibitionAlexey Goltsov, Dana Faratian, Simon P Langdon, et al.
Cellular Signalling|October 19, 2010
Compensatory effects in the PI3K/PTEN/AKT signaling network following receptor tyrosine kinase inhibitionAlexey Goltsov, Dana Faratian, Simon P Langdon, et al.
Journal of Biotechnology|December 3, 2014
Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cellsHilal S Khalil, Alexey Goltsov, Simon P Langdon, et al.
Pageof 3